MRI Biomarkers for Radiation-Induced Neurocognitive Decline Following SRS of Newly Diagnosed Brain Mets
Running, not enrolling
Conditions studied: Brain Metastases, Neurocognitive Deficit, White Matter Alterations, Radiation Exposure
In brief
Brain metastases are a source of much morbidity and mortality in adults with primary solid malignant tumors. With improvements in systemic therapy that prolong survival but have limited central nervous system penetration, patients with brain metastases are at increasing risk of developing and experiencing long-term side effects from treatment of brain metastases. The overarching goal of this study is to better understand the determinants of RT-associated changes in white and gray matter function and associated neurocognitive decline.
Key facts
- Study ID
- NCT04073966
- Run by
- UNC Lineberger Comprehensive Cancer Center
- People needed
- 15
- Starts
- 2019-12-04
- Expected to finish
- 2027-05-28
- Last updated by the study team
- 2026-06-03
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Histologic diagnosis of cancer
- Newly diagnosed brain metastasis being treated with SRS. Any extent of cranial disease permitted. Subsequent courses of SRS while on study permitted when clinically indicated.
- Patients are permitted to have undergone craniotomy and resection of metastasis/metastases if at least 1 other intact metastasis planned for definitive SRS is present. Receiving or previously received systemic therapy also permitted.
- Anticipated life expectancy at least 1 year
- Age ≥ 18 years
- Ability to read and comprehend written English and follow instructions in English
- Ability to provide informed consent
You may not qualify if…
- Previous radiation to the brain or head
- Previous malignancy - other than non-melanomatous skin cancer or cervical carcinoma in situ - and not disease-free for at least 3 years
- Previous severe head or brain injury
- History of a neurological disorder such as Epilepsy, Parkinson's, Alzheimer's, or Dementia
- Prisoners
Where it is running
- University of North Carolina at Chapel Hill, Department of Radiation Oncology — Chapel Hill, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.